CCL5 as an adjuvant for cancer immunotherapy

The critical role of SDF-1/CXCR4 axis in cancer and cancer stem cells metastasis

(2014) S. Gelmini et al.   JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION

CCL5 promotes proliferation of MCF-7 cells through mTOR-dependent mRNA translation

(2009) Thomas T. Murooka et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Monocytes promote tumor cell survival in T-cell lymphoproliferative disorders and are impaired in their ability to differentiate into mature dendritic cells

(2009) R. A. Wilcox et al.   BLOOD

Chemokine CC-ligand 5 production and eosinophil activation into the upper airways of aspirin-sensitive patients

(2009) A. Fuentes-Beltrán et al.   CLINICAL AND EXPERIMENTAL ALLERGY

Inflammation, Microenvironment, and the Immune System in Cancer Progression

(2009) Andrew Keibel et al.   CURRENT PHARMACEUTICAL DESIGN

Pancreatic cancer cells activate CCL5 expression in mesenchymal stromal cells through the insulin-like growth factor-I pathway

(2009) Hideki Makinoshima et al.   FEBS LETTERS

Transgenic expression of human gp100 and RANTES at specific time points for suppression of melanoma

(2009) K Aravindaram et al.   GENE THERAPY

Interleukin (IL)-10 inhibits RANTES-, tumour necrosis factor (TNF)- and nerve growth factor (NGF)-induced mast cell migratory response but is not a mast cell chemoattractant

(2009) Anna Pietrzak et al.   IMMUNOLOGY LETTERS

Targeting the Intratumoral Dendritic Cells by the Oncolytic Adenoviral Vaccine Expressing RANTES Elicits Potent Antitumor Immunity

(2009) Natalia Lapteva et al.   JOURNAL OF IMMUNOTHERAPY

Increased expression of galectin-1 is associated with human oral squamous cell carcinoma development

(2009) Zhang   ONCOLOGY REPORTS

TARC and RANTES enhance antitumor immunity induced by the GM-CSF-transduced tumor vaccine in a mouse tumor model

(2008) Hiroyuki Inoue et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

The inflammatory chemokines CCL2 and CCL5 in breast cancer

(2008) Gali Soria et al.   CANCER LETTERS

CD4+CD25+ regulatory T cells in the small intestinal lamina propria show an effector/memory phenotype

(2008) Z. Guo et al.   INTERNATIONAL IMMUNOLOGY

RANTES-403 polymorphism is associated with reduced risk of gastric cancer in women

(2008) Jyh-Ming Liou et al.   JOURNAL OF GASTROENTEROLOGY

Vaccination with combination of Fit3L and RANTES in a DNA prime-protein boost regimen elicits strong cell-mediated immunity and antitumor effect

(2008) Shuxia Song et al.   VACCINE